Evaluation of99mTc-L-methionine brain SPECT for detection of recurrent brain tumor: A pilot study with radiological and pathological correlation

Acta Radiologica

Volumn 45, Issue 6, 2004, Pages 649-657

  Barai, S ^a   Bandopadhayaya, G P ^a   Julka, P K ^a   Kale, S S ^a   Malhotra, A ^a   Haloi, A K ^a   Seith, A ^a   Sing, N Gopendro ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

99mTc l methionine; Fanbeam collimator; Methionine retention index

Indexed keywords

BRAIN; IRRADIATION; PATHOLOGY; PATIENT TREATMENT; RADIOLOGY;

99MTC-L-METHIONINE; BRAIN SPECT; FANBEAM COLLIMATOR; METHIONINE RETENTION INDEX;

TUMORS;

DIAGNOSTIC AGENT; METHIONINE; RADIOPHARMACEUTICAL AGENT; TECHNETIUM;

ADULT; ARTICLE; BRAIN; BRAIN TUMOR; FEMALE; HUMAN; MALE; METABOLISM; PILOT STUDY; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR RECURRENCE;

ADULT; BRAIN; BRAIN NEOPLASMS; FEMALE; HUMANS; MALE; METHIONINE; NEOPLASM RECURRENCE, LOCAL; PILOT PROJECTS; RADIOPHARMACEUTICALS; TECHNETIUM; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 16644400210     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1080/02841850410006740     Document Type: Article

References (42)

1. Agrawal M, Abraham J, Balis FM, Edgerly M, Stein WD, Bates S, et al. Increased (99m) Tc-sestamibi accumulation in normal liver and drug-resistant tumors after administration of the glycoprotein inhibitor, XR9576. Clin Cancer Res 2003;9:650-6.
2. Bae KT, Piwnica-Worms D. Pharmacokinetic modeling of multidrug resistance P-glycoprotein transport of gamma-emitting substrates. Q J Nucl Med 1997; 41:101-10.
3. Bagni B, Pinna L, Tamarozzi R, Cattaruzzi E, Marzola MC, Bagni I. SPET imaging of intracranial tumours with 99Tcm-sestamibi. Nucl Med Commun 1995; 16:258-64.
4. Barai S, Bandopadhayaya GP, Julka PK, Haloi AK, Seith A, Malhotra A. Evaluation of single photon emission computerised tomography (SPECT) using Tc99m-tetrofosmin as a diagnostic modality for recurrent posterior fossa tumours. J Postgrad Med 2003;49:316-20.
5. 11C)-methionine in brain tumors studied with positron emission tomography. Acta Radiol 1987;28:225-9.
6. Burkard R, Kaiser KP, Wieler H, Klawki P, Linkamp A, Mittelbach L, et al. Contribution of thallium-201-SPECT to the grading of tumorous alterations of the brain. Neurosurg Rev 1992; 15:265-73.
7. Busch H, Davis JR, Honig GR, Anderson DC, Nair PV, Nyhan WL. The uptake of a variety of amino acids into nuclear proteins of tumors and other tissues. Cancer Res 1959;19:1030-9.
8. Chang LT. A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci NS- 1978;25:638-43.
9. Chao ST, Suh JH, Raja S, Lee SY, Barnett G. The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery. Int J Cancer 2001;96:191-7.
10. 11C-L-methylmethionine. Neurosurgery 1997; 40:276-87.
11. Dooms GC, Hecht S, Brant-Zawadzki M, Berthiaume Y, Norman D, Newton TH. Brain radiation lesions: MR imaging. Radiology 1986;158:149-55.
12. Fuster D, Vinolas N, Mallafre C, Pavia J, Martin F, Pons F. Tetrofosmin as predictors of tumour response. Q J Nucl Med 2003;47:58-62.
13. Giglio P, Gilbert MR. Cerebral radiation necrosis. Neurology 2003;9:180-8.
14. 11C-methionine PET for differential diagnosis of low-grade gliomas. Neurology 1998; 50:1316-22.
15. Holan T, Miclutia M, Buchwald I, Imreh S. A new method of labeling methionine with 99mTc. Nucl Med (Stuttg) 1973;12:266-8.
16. Isselbacher KJ. Sugar and amino acid transport by cells in culture: differences between normal and malignant cells. N Engl J Med 1972;286:929-33.
17. Joseph B, Bhargava KK, Malhi H, Schilsky ML, Jain D, Palestro CJ, et al. Sestamibi is a substrate for MDR1 and MDR2 P-glycoprotein genes. Eur J Nucl Med Mol Imaging 2003;30:1024-31.
18. Kallen K, Heiling M, Andersson AM, Brun A, Holtas S, Ryding E. Preoperative grading of glioma malignancy with thallium-201 single-photon emission CT: comparison with conventional CT. Am J Neuroradiol 1996;17:925-32.
19. Kaplan WD, Takvorian T, Morris JH, Rumbaugh CL, Conndly BT, Atkins HL. Thallium-201 brain tumor imaging. A comparative study with pathological correlation. J Nucl Med 1987;28:47-52.
20. Kim CK, Alavi JB, Alavi A, Reivich M. New grading system of cerebral gliomas using positron emission tomography with F-18 fluorodeoxyglucose. J Neurooncol 1991;10:85-91.
21. Kubota K, Matsuzawa T, Ito M, Ito K, Fujiwara T, Abe Y, et al. Lung tumor imaging by positron emission tomography using C-11 L-methionine. J Nucl Med 1985;26:37-42.
22. Kumar AJ, Leeds NE, Fuller GN, Van Tassel P, Maor MH, Sawaya RE, et al. Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment. Radiology 2000;217:377-84.
23. Lam WW, Chan KW, Wong WL, Poon WS, Metreweli C. Pre-operative grading of intracranial glioma. Acta Radiol 2001;42:548-54.
24. Levin VA, Prados MR, Wara WM, Davis RL, Gutin PH, Phillips TL, et al. Radiation therapy and bromodeoxyuridine chemotherapy followed by procarbazine, lomustine, and vincristine for the treatment of anaplastic gliomas. Int J Radiat Oncol Biol Phys 1995;32:75-83.
25. 11C-methionine of intracranial tumours compared with histology of multiple biopsies. Acta Radiol Suppl 1986;369:157-160.
26. Nakamura N, Kojima H, Nagashima K, Aida T, Kaneko S, Kitaoka K, et al. Post-mortem observation of glioma and/or brain tissue compared to C-T scan findings after irradiation. Gan No Rinsho 1989;35:1313-23.
27. Nafe R, Franz K, Schlote W, Schneider B. Quantitative investigation of nuclear morphology in glioblastomas and its relation to survival time. Clin Neuropathol 2003;22:129-36.
28. Ogawa T, Shishido F, Kanno I, Inugami A, Fujita H, Murakami M, et al. Cerebral glioma: evaluation with methionine PET. Radiology 1993; 186:45-53.
29. Oriuchi N, Tamura M, Shibazaki T, Ohye C, Watanabe N. Clinical evaluation of thallium-201 SPECT in supratentorial gliomas: relationship to histological grade, prognosis, and proliferative activities. J Nucl Med 1993;34:2089-90.
30. 99mTc-labeled radiopharmaceuticals. Eur J Nucl Med 1977;2:97-8.
31. Preul MC, Leblanc R, Caramanos Z, Kasrai R, Narayanan S, Arnold DL. Magnetic resonance spectroscopy guided brain tumor resection: differentiation between recurrent glioma and radiation change in two diagnostically difficult cases. Can J Neurol Sci 1998;25:13-22.
32. Pruim J, Willemsen AT, Molenaar WM, van Waarde A, Paans AM, Heesters MA, et al. Brain tumors: L-[1-C-11] tyrosine PET for visualization and quantification of protein synthesis rate. Radiology 1995;197:221-6.
33. Roelcke U, Radu E, Ametamey S, Pellikka R, Steinbrich W, Leenders KL. Association of rubidium and C-methionine uptake in brain tumors measured by positron emission tomography. J Neurooncol 1996;27:163-71.
34. Saier MH Jr, Daniels GA, Boerner P, Lin J. Neutral amino acid transport systems in animal cells: potential targets of oncogene action and regulators of cellular growth. J Membr Biol 1988;104:1-20.
35. 11C-methionine positron emission tomography and proliferating cell nuclear antigen staining. Neurosurg Rev 1999;22:210-14.
36. Shotwell A, Jayme DW, Killberg M, Oxender DL. Neutral amino acid transport systems in Chinese hamster ovary cells. J Biol Chem 1981;256:5422-7.
37. Souba WW, Pacitti AJ. How amino acids get into cells: mechanisms, models, menus and mediators. J Parenter Enteral Nutr 1992;16:569-78.
38. Stokkel M, Stevens H, Taphoorn M, Van Rijk P. Differentiation between recurrent brain tumour and post-radiation necrosis: the value of 201 T1 SPET versus 18F-FDG PET using a dual-headed coincidence camera - a pilot study. Nucl Med Commun 1999;20:411-7.
39. Utriainen M, Metsahonkala L, Salmi TT, Utriainen T, Kalimo H, Pihko H, et al. Metabolic characterization of childhood brain tumors: comparison of 18F-fluorodeoxyglucose and 11C-methionine positron emission tomography. Cancer 2002;95:1376-86.
40. Valk PE, Dillon WP. Radiation injury of the brain. Am J Neuroradiol 1991;12:45-62.
41. Wong TZ, van der Westhuizen GJ, Coleman RE. Positron emission tomography imaging of brain tumors Neuroimaging. Clin N Am 2002;12:615-26.
42. Yoshii Y, Satou M, Yamamoto T, Yamada Y, Hyodo A, Nose T, et al. The role of Thallium-201 single photon emission tomography in the investigation and characterization of brain tumor and their response to treatment. Eur J Nucl Med 1993;20:39-45.